» Articles » PMID: 627016

Sequestration of Neuraminidase-treated Erythrocytes. Studies on Its Topographic, Morphologic and Immunologic Aspects

Overview
Journal Cell Tissue Res
Date 1978 Jan 17
PMID 627016
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Scintigraphic experiments and radioactivity measurements of tissues have shown that the radioactivity of 51Cr-labelled and neuraminidase-treated rabbit erythrocytes is rapidly accumulated in liver and spleen. Sequestration of these erythrocytes by liver and spleen was demonstrated by light and electron microscopy of theses tissues after perfusion of the rabbits with solutions for tissue fixation. In liver the phagocytic activity of Kupffer cells was increased after injection of desialylated erythrocytes, while in spleen a significantly enhanced number of erythrocytes was found attached to the sinusoidal walls and in the reticulum of the red pulp. It was shown by scanning electron microscopy that neuraminidase-treatment did not influence the shape of erythrocytes. Desialylated and 51Cr-labelled erythrocytes from the cow are rapidly cleared from the blood-stream with a half-life time of about 3 h. It was shown in an in-vitro test that they adsorb to surviving slices from liver and spleen derived from the same animal. The amount of radioactivity adsorbed is appreciably enhanced in the presence of homologous serum when compared with buffer only. Human neuraminidase-treated erythrocytes are agglutinated in the direct and especially in the indirect Coombs-tests. The involvement of T-antigen in this phenomenon was largely excluded. The in vitro experiments and antibody consumption tests suggest that immunoglobulins (IgG) and complement from serum may be involved in recognition and sequestration of desialylated erythrocytes by macrophages in vivo.

Citing Articles

Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes.

Zheng C, Li S, Lyu H, Chen C, Mueller J, Dropmann A Hepat Med. 2024; 16:65-77.

PMID: 39247515 PMC: 11380495. DOI: 10.2147/HMER.S469990.


Exploration of the Sialic Acid World.

Schauer R, Kamerling J Adv Carbohydr Chem Biochem. 2018; 75:1-213.

PMID: 30509400 PMC: 7112061. DOI: 10.1016/bs.accb.2018.09.001.


Sialic acids as link to Japanese scientists.

Schauer R Proc Jpn Acad Ser B Phys Biol Sci. 2016; 92(4):109-20.

PMID: 27063181 PMC: 4989050. DOI: 10.2183/pjab.92.109.


Iron overload in Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death.

Penha-Goncalves C, Gozzelino R, de Moraes L Front Pharmacol. 2014; 5:155.

PMID: 25071574 PMC: 4077027. DOI: 10.3389/fphar.2014.00155.


Sialic acid in cardiovascular diseases.

Nigam P, Narain V, Kumar A Indian J Clin Biochem. 2012; 21(1):54-61.

PMID: 23105570 PMC: 3453784. DOI: 10.1007/BF02913067.


References
1.
Schauer R, Veh R, Wember M . Demonstration of neuraminidase activity in human blood serum and human milk using a modified, radioactively labelled alpha1-glycoprotein as substrate. Hoppe Seylers Z Physiol Chem. 1976; 357(4):559-66. DOI: 10.1515/bchm2.1976.357.1.559. View

2.
Poschmann A, Fischer K . [Hemolytic-uremic syndrome. Review and new pathogenetic aspects]. Med Klin. 1974; 69(45):1821-34. View

3.
Chien S, COOPER Jr G, Jan K, MILLER L, Howe C, Usami S . N-acetylneuraminic acid deficiency in erythrocyte membranes: biophysical and biochemical correlates. Blood. 1974; 43(3):445-60. View

4.
Drzeniek R . Substrate specificity of neuraminidases. Histochem J. 1973; 5(3):271-90. DOI: 10.1007/BF01004994. View

5.
Logue G, Rosse W, Gockerman J . Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin Invest. 1973; 52(2):493-501. PMC: 302279. DOI: 10.1172/JCI107206. View